Klaire Labs, ProThera and Complementary Prescriptions to Be Unified Under Klaire Labs Brand
Reno, NV (July 7, 2017)— Klaire Labs, parent SFI USA, announced today that its sister brands,
ProThera and Complementary Prescriptions will begin a transition to unify under a single brand
moving forward: Klaire Labs. As a component of this transition, the company will also introduce
a modernized design based on the legacy Klaire logo.
Harmonization of the three originator brands demonstrates the company’s renewed
commitment to Klaire’s founding principles of purity and potency. As such, every product will
now be evaluated through the highly discriminating Klaire Labs quality lens.
“Claire Farr founded Klaire Labs at her kitchen table with a dream to create supplements pure
enough that highly sensitive individuals like herself could tolerate reliably,” said Ilene Buchholz,
RN, a former colleague of Claire Farr and current technical education lead for Klaire Labs. “She
was truly a humanitarian as well as a consummate entrepreneur dedicated to providing the
purest, most potent, pharmacy grade nutraceuticals.”
Since the acquisition by Soho Flordis International (SFI) in 2013, the three originating brands in
Reno have benefited by both aligned philosophy and significant investment. The newly
harmonized Klaire Labs boasts a new, purpose-built, 75,000 square foot state-of-the-art
manufacturing facility, along with a renewed commitment to optimized quality processes,
advanced formulation expertise, and significantly expanded manufacturing capability.
“We want our practitioners to know that the new facility and unification of brands are only the
outward manifestations of our growth,” said Jeremy Appleton, ND, Vice President of Scientific
and Regulatory Affairs. “Internally, these changes are supported by investments in robust and
streamlined quality systems, experienced staff, and regulatory and production expertise second
to none. There have been some bumps along the way, but we are confident these changes will
have the ultimate effect of elevating us far above most companies operating in this channel.
Such improvements tangibly support practitioners in their patient care, including a pipeline of
new and innovative products.”
As a component of the unification, practitioners can expect to see a new, modernized branding
with a clear and respectful nod to the legacy Klaire Labs logo and labeling. The refreshed look
will begin to surface in late 2017.
For more information and FAQs on the unification of ProThera and Complementary
Prescriptions under the Klaire Labs umbrella, to learn the Claire Farr story, and to subscribe to
updates on the consolidation, please visit MeetKlaire.com.
About Klaire Labs
Klaire Labs has been formulating and manufacturing premium, hypoallergenic supplements sold
through healthcare practitioners for nearly half a century. Our mission is to develop and
manufacture the purest, most potent nutraceuticals possible, thereby empowering clinicians
with consistently reliable performance.
Klaire Labs is located in Reno, NV. It is owned by Soho Flordis International, a privately held
nutraceutical company based in Sydney, Australia.